OBJECTIVE: The concept of skeletal muscle homeostasis--often viewed as the net balance between two separate processes, namely protein degradation and protein synthesis--are not occurring independently of each other, but are finely co-ordinated by a web of intricate signalling networks. MATERIALS AND METHODS: Using rodent muscle cell lines we have investigated TNF-alpha/IGF-I interactions, in an attempt to mimic and understand mechanisms underlying the wasting process. RESULTS AND CONCLUSION: When myoblast cells are incubated with TNF-alpha (10 ng ml(- 1)) maximal damage ( approximately 21% +/- 0.7 myoblast death, p < 0.05) was induced. Co-incubation of TNF-alpha (10 ng ml(- 1)) with IGF-I resulted in cell survival ( approximately 50% reduction in myoblast death, p < 0.05), however, myotube formation was not evident. In contrast, a novel role of IGF-I has been identified whereby co-incubation of muscle cells with IGF-I (1.5 ng ml(- 1)) and a non-apoptotic dose of TNF-alpha (1.25 ng ml(- 1); sufficient to block differentiation) unexpectedly were shown not to rescue a block on differentiation but to facilitate significant myoblast death (p < 0.05). Interestingly, pre-administration of PD98059, a MAPK signal-blocking agent followed by co-incubation of 1.25 ng ml(- 1) TNF-alpha and 1.5 ng ml(- 1) IGF-I, reduced death to baseline levels (p < 0.05). We show for the first time that IGF-I can be apoptotic in the absence of TNF-alpha-induced cell death.
OBJECTIVE: The concept of skeletal muscle homeostasis--often viewed as the net balance between two separate processes, namely protein degradation and protein synthesis--are not occurring independently of each other, but are finely co-ordinated by a web of intricate signalling networks. MATERIALS AND METHODS: Using rodent muscle cell lines we have investigated TNF-alpha/IGF-I interactions, in an attempt to mimic and understand mechanisms underlying the wasting process. RESULTS AND CONCLUSION: When myoblast cells are incubated with TNF-alpha (10 ng ml(- 1)) maximal damage ( approximately 21% +/- 0.7 myoblast death, p < 0.05) was induced. Co-incubation of TNF-alpha (10 ng ml(- 1)) with IGF-I resulted in cell survival ( approximately 50% reduction in myoblast death, p < 0.05), however, myotube formation was not evident. In contrast, a novel role of IGF-I has been identified whereby co-incubation of muscle cells with IGF-I (1.5 ng ml(- 1)) and a non-apoptotic dose of TNF-alpha (1.25 ng ml(- 1); sufficient to block differentiation) unexpectedly were shown not to rescue a block on differentiation but to facilitate significant myoblast death (p < 0.05). Interestingly, pre-administration of PD98059, a MAPK signal-blocking agent followed by co-incubation of 1.25 ng ml(- 1) TNF-alpha and 1.5 ng ml(- 1) IGF-I, reduced death to baseline levels (p < 0.05). We show for the first time that IGF-I can be apoptotic in the absence of TNF-alpha-induced cell death.
Authors: Janwillem Testerink; Richard T Jaspers; Jörn Rittweger; Arnold de Haan; Hans Degens Journal: J Physiol Sci Date: 2011-09-11 Impact factor: 2.781
Authors: Jatin G Burniston; Thomas H Meek; Sachchida Nand Pandey; Gina Broitman-Maduro; Morris F Maduro; Anne M Bronikowski; Theodore Garland; Yi-Wen Chen Journal: Physiol Genomics Date: 2013-01-29 Impact factor: 3.107
Authors: Emanuele Marzetti; Giuseppe Privitera; Vincenzo Simili; Stephanie E Wohlgemuth; Lorenzo Aulisa; Marco Pahor; Christiaan Leeuwenburgh Journal: ScientificWorldJournal Date: 2010-02-19
Authors: Adam P Sharples; David C Hughes; Colleen S Deane; Amarjit Saini; Colin Selman; Claire E Stewart Journal: Aging Cell Date: 2015-04-10 Impact factor: 9.304
Authors: Amarjit Saini; Eric Rullman; Mats Lilja; Mirko Mandić; Michael Melin; Karl Olsson; Thomas Gustafsson Journal: PLoS One Date: 2018-02-05 Impact factor: 3.240
Authors: Frans van Valen; Henning Harrer; Marc Hotfilder; Uta Dirksen; Thomas Pap; George Gosheger; Hans-Ulrich Humpf; Heribert Jürgens Journal: Sarcoma Date: 2012-10-03
Authors: R M Erskine; D J Tomlinson; C I Morse; K Winwood; P Hampson; J M Lord; G L Onambélé Journal: Int J Obes (Lond) Date: 2016-08-29 Impact factor: 5.095